Trending NewsTrending NewsNYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $19.73 -0.01 (-0.03%) Closing price 11/13/2026 03:59 PM EasternExtended Trading$19.39 -0.34 (-1.70%) As of 11/13/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Hims & Hers Health Stock (NYSE:HIMS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Hims & Hers Health alerts:Sign Up Key Stats Today's Range$19.18▼$20.1650-Day Range$19.03▼$30.8752-Week Range$13.74▼$40.99Volume10.01 million shsAverage Volume15.21 million shsMarket Capitalization$4.60 billionP/E RatioN/ADividend YieldN/APrice Target$31.53Consensus RatingHold Company Overview Hims & Hers Health, Inc. operates a consumer-focused telehealth platform that connects patients with licensed healthcare providers and offers access to treatments and wellness products. Its services include online consultations, prescription care and over-the-counter products. The company serves a range of health needs, including hair loss, sexual health, skin care, mental health and weight management. Its platform also offers primary care and other services, with offerings varying by location and individual eligibility. Founded in 2017, the company initially launched its Hims brand and later introduced Hers, expanding its services to a broader audience. Co-founder Andrew Dudum serves as chief executive officer. Hims & Hers is based in the United States and has expanded into select international markets.AI Generated. May Contain Errors. Read More Hims & Hers Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks58th Percentile Overall ScoreHIMS MarketRank™: 2.891156462585 of 5 starsHims & Hers Health scored higher than 58% of companies evaluated by MarketBeat, and ranked 422nd out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingHims & Hers Health has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on no strong buy ratings, 3 buy ratings, 12 hold ratings, and 1 sell rating.Upside PotentialHims & Hers Health has a consensus price target of $31.53, representing about 59.9% upside from its current price of $19.73.Amount of Analyst CoverageHims & Hers Health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Hims & Hers Health are expected to grow in the coming year, from ($0.21) to $0.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is -23.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is -23.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 12.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted25.09% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 5.84.Change versus previous monthShort interest in Hims & Hers Health has recently decreased by 3.40%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. News and Social Media1.7 / 5News Sentiment-0.25 News SentimentHims & Hers Health has a news sentiment score of -0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 63 news articles for Hims & Hers Health this week, compared to 8 articles on an average week.Search InterestOnly 47 people have searched for HIMS on MarketBeat in the last 30 days. This is a decrease of -28% compared to the previous 30 days.MarketBeat Follows15 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 36% compared to the previous 30 days. Company Ownership1.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,826,977.00 in company stock.Percentage Held by Insiders11.76% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. Receive HIMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HIMS Stock News HeadlinesWhat Hims & Hers Health Investors Missed Before The FallNovember 14 at 9:24 AM | finance.yahoo.comWhy is Hims stock crashing, and is it a buying opportunity?November 14 at 9:24 AM | msn.com$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.November 14 at 1:00 AM | Profits Run (Ad)Hims & Hers Stock Just Plummeted 17%. Is the Stock a Buy Ahead of a Peptide Push?November 13 at 12:40 PM | fool.comNebraska joins FTC suit against Hims & Hers over privacy practicesNovember 13 at 3:04 AM | omaha.comOHims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffHims & Hers stock sank after a Q3 earnings and revenue miss, lower EBITDA guidance, subscriber declines, and an expanding FTC lawsuit over privacy and billing practices.November 12 at 8:20 AM | marketbeat.comHims & Hers Health (NYSE:HIMS) Stock: Insider Soleil Boughton Sells 3,462 SharesOctober 30, 2026 | insidertrades.comHims & Hers Health (NYSE:HIMS) Insider Sells $100,576.66 in StockOctober 16, 2026 | insidertrades.comSee More Headlines HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $32.45 at the beginning of the year. Since then, HIMS stock has decreased by 39.2% and is now trading at $19.7250. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) announced its quarterly earnings results on Monday, November, 9th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by $0.03. The firm's quarterly revenue was up 48.6% on a year-over-year basis. Read the conference call transcript. Is Hims & Hers Health doing a stock buyback? Hims & Hers Health's board authorized a stock repurchase program on Monday, November 17th 2025, which allows the company to buy back $250 million in outstanding shares, according to EventVestor. This means that the company could repurchase up to 3% of its stock through open market purchases. Stock buyback programs are often a sign that the company's leadership believes its shares are undervalued. Who are Hims & Hers Health's major shareholders? Top institutional investors of Hims & Hers Health include State Street Corp (3.53%), Greenfield Seitz Capital Management LLC (0.17%), Commonwealth Equity Services LLC (0.12%) and First Trust Advisors LP (0.10%). Insiders that own company stock include Melissa Baird, Michael Chi, Soleil Boughton, Oluyemi Okupe, David B Wells, Patrick Harrison Carroll, Christopher D Payne, Andrew Dudum, Garcia Andrea G Perez, Deborah M Autor, Christiane Pendarvis, Irene Becklund, Irene Becklund, Anja Manuel and Lynne Chou O'keefe. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Hims & Hers Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Tesla (TSLA), SoFi Technologies (SOFI), Super Micro Computer (SMCI) and Micron Technology (MU). Company Calendar Last Earnings11/09/2026Today11/14/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (5d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 As of 5 days ago, HIMS's financial health entered the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:HIMS CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees2,442Year Founded2017Price Target and Rating Average Price Target for Hims & Hers Health$31.53 High Price Target$60.00 Low Price Target$23.00 Potential Upside/Downside+59.9%Consensus RatingHold Rating Score (0-4)2.13 Research Coverage16 Analysts Profitability EPS (Trailing Twelve Months)($0.83) Trailing P/E RatioN/A Forward P/E Ratio657.50 P/E GrowthN/ANet Income$128.37 million Net Margins-6.65% Pretax Margin-7.74% Return on Equity-9.62% Return on Assets-1.38% Debt Debt-to-Equity Ratio3.85 Current Ratio0.92 Quick Ratio0.87 Sales & Book Value Annual Sales$2.35 billion Price / Sales1.96 Cash Flow$0.84 per share Price / Cash Flow23.58 Book Value$1.52 per share Price / Book12.98Miscellaneous Outstanding Shares233,310,000Free Float205,875,000Market Cap$4.60 billion OptionableOptionable Beta2.53 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:HIMS) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredElon wants to move AI off the planet. Amazon isn't ready.What if the next AI race isn't on Earth? Tim Bohen's Mission X presentation explores Elon Musk's idea of movin...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
